Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IPXLE

Impax labs (IPXLE)

Impax Laboratories (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPXLE
DateTimeSourceHeadlineSymbolCompany
01/19/20173:27PMDow Jones NewsRival to EpiPen Allergy Treatment to Return to Market--UpdateNASDAQ:IPXLEImpax Laboratories (MM)
01/19/20172:17PMDow Jones NewsRival to EpiPen Allergy Treatment to Return to MarketNASDAQ:IPXLEImpax Laboratories (MM)
01/12/20174:03PMDow Jones NewsCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- UpdateNASDAQ:IPXLEImpax Laboratories (MM)
11/03/20163:08PMDow Jones NewsDOJ Looking Into Possible Price Collusion in Generic Drug Sector -BloombergNASDAQ:IPXLEImpax Laboratories (MM)
07/27/20166:41PMDow Jones NewsCorrection to Teva, Allergan ArticleNASDAQ:IPXLEImpax Laboratories (MM)
07/27/20163:00PMDow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
07/27/20162:51PMDow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
07/12/20166:20PMDow Jones NewsTeva Raises GuidanceNASDAQ:IPXLEImpax Laboratories (MM)
06/22/20162:07AMDow Jones NewsBusiness Watch -- WSJNASDAQ:IPXLEImpax Laboratories (MM)
06/21/20168:30AMDow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
06/21/20168:17AMDow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
03/31/201610:50AMDow Jones NewsFTC Accuses Endo of Paying Off Generic DrugmakersNASDAQ:IPXLEImpax Laboratories (MM)
09/22/201510:50PMDow Jones NewsTuring to Cut Price of Drug Daraprim After OutcryNASDAQ:IPXLEImpax Laboratories (MM)
08/05/20053:00AMBusiness WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
08/05/20053:00AMBusiness WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
08/03/20053:00AMBusiness WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
08/03/20053:00AMBusiness WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
06/27/20056:00AMBusiness WireIMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to beNASDAQ:IPXLEImpax Laboratories (MM)
06/20/20057:01AMBusiness WireIMPAX to Increase Existing Credit FacilityNASDAQ:IPXLEImpax Laboratories (MM)
05/04/20058:03AMBusiness WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
05/04/20058:03AMBusiness WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
05/02/200510:01AMBusiness WireCORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20NASDAQ:IPXLEImpax Laboratories (MM)
05/02/20058:24AMBusiness WireIMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005NASDAQ:IPXLEImpax Laboratories (MM)
 Showing the most relevant articles for your search:NASDAQ:IPXLE